Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 742 of 6351
-
Can a single gene therapy injection ease diabetic macular edema?
Disease control CompletedThis is a clinical study to evaluate the safety, tolerability and initial efficacy of SKG0106 intravitreal injection in diabetic macular edema (DME) patients.
Phase 1 • Sponsor: Wang Min • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New lung cancer pill targets resistant mutations in early trial
Disease control Recruiting nowHS-10504 is a fourth-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor targeting EGFR C797S mutation. This study will evaluate the safety, tolerability, pharmacokinetics and efficacy of HS-10504 in Chinese locally advanced or metastatic NSCLC.
Phase 1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New immune therapy combo aims to keep myeloma in check
Disease control OngoingThis is a Phase 2 study, open-label, 2-cohort, multicenter, national, interventional in patients with newly diagnosed multiple myeloma. The study will investigate teclistamab (Tec) in combination with lenalidomide (Len) (Tec-Len; Cohort A) or in combination with talquetamab (Tal)…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could early rectal cancer patients skip radiation? new trial aims to find out
Disease control Recruiting nowThis study is being done to answer the following questions: Is the chance of rectal cancer responding the same if chemotherapy alone is given before limited surgery compared to chemotherapy and radiation therapy given together before limited surgery? If radiation therapy is not g…
Phase 3 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a DIY swab replace the pelvic exam for cervical cancer screening?
Diagnosis OngoingThis clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cervical excisional procedures to improve cervical cancer prevention. HPV is a common virus which usually causes infections …
Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Recruiting nowTo find a recommended dose of PRAME-TCR-NK cells that can be given to patients with AML or MDS.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
New gout pill shows promise in large trial
Disease control CompletedThis study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 months
Phase 3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a targeted nerve block replace opioids after stomach cancer surgery?
Symptom relief CompletedOpen Gastrectomy surgery is a big surgery with upper umbilical median incision where the postoperative pain is occur frequently. pain managements of this surgery with intravenous opioid analgesics are currently standard approach. but its side effects as sedation, decreased bowel …
Sponsor: TC Erciyes University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can a targeted therapy tame a rare blood cancer in everyday practice?
Disease control Recruiting nowThe main goal of this registry study is to investigate the effectiveness and safety of tagraxofusp in the treatment of adult participants with BPDCN in the real-world clinical practice setting.
Sponsor: Stemline Therapeutics, Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Timing of steroids could save lives in sepsis
Disease control Stopped earlyThe goal of this clinical trial is to compare two timings of steroid treatment in patients with severe infection who develop low blood pressure. The main question it aims to answer is: • Which timing strategy is better between starting steroid treatment very early in the course…
Sponsor: Siriraj Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a pill tame muscle weakness in myasthenia gravis?
Disease control Recruiting nowThe purpose of this clinical study is to determine the efficacy and safety of a new oral cladribine formulation in participants with Generalized Myasthenia Gravis (gMG) in comparison to placebo. It will also investigate the sustained efficacy, the need for retreatment, and the lo…
Phase 3 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Brain zaps may curb stimulant cravings and lift depression
Disease control Recruiting nowThis study is a small open-label feasibility trial of an accelerated course of repetitive transcranial magnetic stimulation (rTMS) for individuals with depression and stimulant use disorder \[including methamphetamine or cocaine use disorder (MUD/CUD)\].
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug duo aims to shrink tough cancers
Disease control Recruiting nowThis phase II study is a clinical study to explore the efficacy and safety of BL-B01D1 combined with PD-1 Monoclonal Antibody in patients with locally advanced or metastatic non-small cell lung cancer, nasopharyngeal carcinoma and other solid tumors.
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New injection shows promise for relieving intense itching
Symptom relief CompletedThis study is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study to evaluate the efficacy and safety of Stapokibart Injection in the treatment of subjects with prurigo nodularis, and observe pharmacokinetic characteristics, pharmacological effect…
Phase 3 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New psoriasis drug shows promise for kids in Head-to-Head trial
Disease control OngoingThe primary purpose of this study is to evaluate the efficacy of bimekizumab administered subcutaneously (sc) compared to active control (ustekinumab) in children and adolescents aged 6 to \<18 years of age with moderate to severe plaque psoriasis (PSO).
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Ultrasound may help doctors time lifesaving lung treatment for preterm infants
Diagnosis Recruiting nowPoint-of-care ultrasound (POCUS) is the use of ultrasound by the bedside provider in real time to answer a specific question and guide medical management. POCUS can be used to diagnose the severity of neonatal respiratory distress syndrome (RDS) through a lung ultrasound score. L…
Sponsor: Connecticut Children's Medical Center • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
New combo aims to shrink tumors and cut radiation for young cancer patients
Disease control Recruiting nowThis phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
AI eye exam could save premature Babies' sight
Diagnosis OngoingThe purpose of the pivotal reader study is to assess the readers' accuracy in diagnosing plus disease versus no plus or pre-plus disease with or without the aid of the i-ROP DL. Ophthalmologists' performance metrics for the following modalities will be evaluated: * Standard eval…
Sponsor: Siloam Vision • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Earlier hormone therapy: a lifeline for transgender teens?
Disease control Recruiting nowGender dysphoria (GD) is a significant suffering lasting more than 6 months in a subject, with regard to the discrepancy felt between his or her gender identity and his or her birth sex. From the onset of puberty, most of these self-identified transgender adolescents will persist…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can custom ventilation save more ARDS lungs?
Disease control Recruiting nowThe goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress Syndrome (ARDS). Participants will be ventilated according to one of two different strategies. The main q…
Phase 3 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC